GMED · Large Cap · NYSE · Healthcare · Medical Devices
Free AI brief
Free to track. No card required. Usually ready in 10-15 minutes.
Price, momentum, and the numbers behind the story.
Stocksbrew score
78/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Where the analysts and the crowd stand, and what it's worth to know first.
Current price
$76.25
Lowest
$84
Median target
$100
Highest
$125
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
Forward P/E
Favorable · 9% below avg
14.63x
Price / FCF
Strong · Cash flow supports price
13.26x
EV / EBITDA
Strong · Earnings support price
9.20x
Debt / equity
Favorable · 0.02 - strong leverage
0.02x
Current ratio
Strong · Good liquidity position
4.62x
GMED against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $10.02B | 19.1 | +19.7% | 78 | |
| $31.74B | 33.2 | +15.5% | 78 | |
| $4.23B | 12.7 | +13.5% | 78 | |
| $1.11T | 40.1 | +49.6% | 77 | |
| $61.93B | 17.3 | +13.5% | 73 |